#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Microvillous inclusion disease Sjogren's syndrome Bone marrow disorder Inflammatory myofibroblastic tumour Subdural haematoma Congenital aplastic anaemia Neonatal alloimmune thrombocytopenia Cardiac sarcoidosis Congenital growth hormone deficiency Hydrocephalus Chronic kidney disease Mixed-type liposarcoma Necrotising enterocolitis neonatal Amyotrophic lateral sclerosis gene carrier Dilated cardiomyopathy More trials…

    Learn about Rare Diseases

    Osteosarcoma – Basic Information Myxofibrosarcoma – Life with Disease Antisynthetase syndrome – Basic Information Hepatoblastoma – Basic Information Angiosarcoma non-metastatic – Treatment Advanced systemic mastocytosis – Treatment Haemophilia B with anti factor IX – Diagnostics Systemic sclerosis pulmonary – Treatment Langerhans cell sarcoma – Basic Information Mantle cell lymphoma stage IV – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ibutamoren Mesilate Olmesartan Medoxomil Vo659 Festuca Rubra Pollen Dipyridamole Alks 2680 Cocarboxylase Tetrahydrate GXV813 Oxogluric Acid Teropavimab Aceclofenac PRT3789 Triamcinolone ZILUCOPLAN NERANDOMILAST Glimepiride Darunavir TUVATEXIB L-Histidine Hydrochloride Cls12311 More therapies…

    Learn about Your Condition

    Langerhans cell sarcoma Alopecia areata Anaemia of pregnancy Optic atrophy Renal cancer Status epilepticus Meniscus operation Colon cancer Deep vein thrombosis Pseudomonas infection Dilated cardiomyopathy Ependymoma Pseudomyxoma peritonei Colon cancer metastatic Pancreatitis chronic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Overweight

  • Study on Metformin and Lifestyle Changes for Girls with Early Puberty and Overweight

    Recruiting

    2 1 1
    Investigated Diseases:
    • Precocious puberty
    • Overweight
    Investigated Drugs:
    • Metformin Hydrochloride
    Denmark

  • Study on the Effects of Tirzepatide on Heart Health in Overweight and Obese Patients with Coronary Artery Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Saline
    • Tirzepatide
    Denmark

  • Study comparing two forms of cagrilintide with placebo for weight loss in adults with overweight or obesity

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Cagrilintide
    Greece Hungary Portugal Sweden

  • Study of PF-08653945 Bioavailability After Subcutaneous Injection in the Thigh, Upper Arm, or Abdomen in Adults with Obesity

    Recruiting

    1 1 1
    Investigated Diseases:
    • Overweight
    Belgium

  • Effect of semaglutide, acetylsalicylic acid, and clopidogrel on blood clotting in patients with diabetes or overweight with cardiovascular disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Investigated Drugs:
    • Clopidogrel
    • Acetylsalicylic Acid
    • Semaglutide
    Italy

  • Study on the Safety and Effects of AZD9550 for Overweight and Obese Patients with Non-Alcoholic Steatohepatitis (NASH) with or without Type 2 Diabetes

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • AZD6234
    • Azd9550
    • Calcium
    Austria Germany Sweden
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!